| Cited in | Search | Type: | Non-patent literature | Publication information: | [A] - MURAGURI ET AL, "Clinical efficacy and plasma concentrations of two formulations of buparvaquone in cattle infected with East Coast fever (Theileria parva infection)", RESEARCH IN VETERINARY SCIENCE, BRITISH VETERINARY ASSOCIATION, LONDON, GB, (200608), vol. 81, no. 1, doi:10.1016/J.RVSC.2005.09.012, ISSN 0034-5288, pages 119 - 126, XP005315869 [A] 1-10 * the whole document * * page 120, column L * | DOI: | http://dx.doi.org/10.1016/j.rvsc.2005.09.012 | Type: | Non-patent literature | Publication information: | [A] - GANTALA VENKATESH ET AL, "In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, (201006), vol. 36, no. 6, doi:10.3109/03639040903460446, ISSN 0363-9045, pages 735 - 745, XP055123104 [A] 1-10 * the whole document * | DOI: | http://dx.doi.org/10.3109/03639040903460446 | Type: | Non-patent literature | Publication information: | [A] - MANTYLA A ET AL, "Design, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, ELSEVIER, AMSTERDAM, NL, (200410), vol. 23, no. 2, doi:10.1016/J.EJPS.2004.06.006, ISSN 0928-0987, pages 151 - 158, XP004580038 [A] 1-10 * the whole document * | DOI: | http://dx.doi.org/10.1016/j.ejps.2004.06.006 |
